Use Of Whey Protein Micelles For Controlling Postprandial Glucose Response
Patent No. EP3982992 (titled "Use Of Whey Protein Micelles For Controlling Postprandial Glucose Response") was filed by Nestle on Jun 11, 2020. The application was issued on Jan 15, 2025.
Patent Summary
Whey protein micelles administered before a meal can significantly reduce postprandial glucose levels by activating a natural feedback mechanism that regulates glucose uptake in the body. The micelles, which are already present in the digestive system, work by binding to specific receptors in the small intestine and enhancing the absorption of glucose from the meal, thereby preventing postprandial spikes. This approach offers a novel, non-invasive strategy for managing postprandial glucose levels that can be particularly beneficial for individuals with insulin resistance or those at risk of developing diabetes.
Patent Family
Patent Oppositions (2)
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP3982992
- Application Number
- EP20731864A
- Filing Date
- Jun 11, 2020
- Status
- Granted And Under Opposition
- Dec 13, 2024
- Publication Date
- Jan 15, 2025
- External Links
- Slate, Register , Google Patents